Mindfulness in High Risk Pregnancies
Launched by UNIVERSITY OF ALBERTA · Jul 30, 2020
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring the use of mindfulness techniques to help pregnant women who are at risk of delivering their babies early, known as preterm delivery. High-risk pregnancies often come with increased feelings of anxiety, depression, and stress, which can negatively affect both the mother and the baby. The trial aims to teach mindfulness skills to these mothers during their hospital stay to see if it can help reduce their anxiety, stress, and depression.
To participate, mothers must be admitted to the hospital for the risk of preterm delivery (before 34 weeks of pregnancy) and expect to stay for at least four weeks. They should be able to understand and communicate in English and be willing to attend mindfulness sessions. Throughout the study, participants will complete questionnaires before and after the mindfulness program to measure any changes in their feelings and will also keep a weekly log of their mindfulness practice. This research may lead to future programs that offer mindfulness to support mothers in high-risk pregnancies, both in the hospital and after they go home.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Pregnant mothers admitted to the antepartum ward at the Lois Hole Hospital for risk of preterm delivery (\< 34 weeks GA) are eligible for the study.
- • if they speak, read and write English,
- • if their inpatient stay is anticipated to be at least 4 weeks following recruitment
- • if they are willing and able to attend the mindfulness sessions.
- Exclusion Criteria:
- • if they are experiencing current mental illness issues
- • if they are experiencing current or prior substance abuse
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Marc-Antoine Landry, MD
Principal Investigator
University of Alberta
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials